Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer

Clinical Genetics

Volumn 71, Issue 4, 2007, Pages 331-342

  Lim, Y K ^a   Iau, P T C ^b   Ali, A B ^a   Lee, S C ^b   Wong, J E ^b   Putti, T C ^b   Sng, Jen Hwei ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Asian population; BRCA1; BRCA2; Breast ovarian cancer; Genomic rearrangements

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADOLESCENT; ADULT; ARTICLE; ASIAN; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; EXON; FAMILY HISTORY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC RISK; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGAPORE;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BREAST NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; EXONS; FEMALE; GENE REARRANGEMENT; GENES, BRCA1; GENES, BRCA2; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OVARIAN NEOPLASMS; SEQUENCE DELETION; SINGAPORE;

EID: 34247563394     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00773.x     Document Type: Article

References (63)

1. Burke W, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 1997: 277: 997-1003.
2. Hendrickson BC, Judkins T, Ward BD et al. Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families. Genes Chromosomes Cancer 2005: 43: 309-313.
3. Walsh T, Casadei S, Coats KH et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP5 3 in families at high risk of breast cancer. JAMA 2006: 295: 1379-1388.
4. Mazoyer S. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 2005: 25: 415-422.
5. Berry DA, Iversen ES Jr, Gudbjartsson DF et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 2002: 20: 2701-2712.
6. Frank TS, Deffenbaugh AM, Reid JE et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10000 individuals. J Clin Oncol 2002: 20: 1480-1490.
7. Sng JH, Chang J, Feroze F et al. The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer 2000: 82: 538-542.
8. Sng JH, Ali AB, Lee SC et al. BRCA1 c.2845insA is a recurring mutation with a founder effect in Singapore Malay women with early onset breast/ ovarian cancer. J Med Genet 2003: 40: e117.
9. Lynch HT, Guirgis HA, Albert S et al. Familial association of carcinoma of the breast and ovary. Surg Gynecol Obstet 1974: 138: 717-724.
10. American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility, Adopted on February 20. J Clin Oncol 1996: 14: 1730-1736; discussion 1737-1740.
11. Sambrook J, Russell DW. Isolation of high-molecular with DNA from mammalian cells. In: Molecular cloning a laboratory manual, 3rd edn. New York: Cold Spring Harbor Laboratory Press 2001.
12. The BRCA1 Exon 13 Duplication Screening Group. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. Am J Hum Genet 2000: 67: 207-212.
13. Puget N, Torchard D, Serova-Sinilnikova OM et al. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res 1997: 57: 828-831.
14. Nordling M, Karlsson P, Wahlstrom J, Engwall Y, Wallgren A, Martinsson T. A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Cancer Res 1998: 58: 1372-1375.
15. Shattuck-Eidens D, Oliphant A, McClure M et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA 1997: 278: 1242-1250.
16. Smith TM, Lee MK, Szabo CI et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 1996: 6: 1029-1049.
17. Montagna M, Dalla Palma M, Menin C et al. Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 2003: 12: 1055-1061.
18. Unger MA, Nathanson KL, Calzone K et al. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 2000: 67: 841-850.
19. Gad S, Aurias A, Puget N et al. Color bar coding the BRCA1 gene on combed DNA: A useful strategy for detecting large gene rearrangements. Genes Chromosomes Cancer 2001: 31: 75-84.
20. Casilli F, Di Rocco ZC, Gad S et al. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments. Hum Mutat 2002: 20: 218-226.
21. Barrois M, Bieche I, Mazoyer S, Champeme MH, Bressac-de Paillerets B, Lidereau R. Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families. Clin Genet 2004: 65: 131-136.
22. Hogervorst FB, Nederlof PM, Gille JJ et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 2003: 63: 1449-1453.
23. Boeke JD. LINEs and Alus-the polyA connection. Nat Genet 1997: 16: 6-7.
24. Mathias SL, Scott AF, Kazazian HH Jr, Boeke JD, Gabriel A. Reverse transcriptase encoded by a human transposable element. Science 1991: 254: 1808-1810.
25. Kazazian HH Jr, Moran JV. The impact of L1 retrotransposons on the human genome. Nat Genet 1998: 19: 19-24.
26. Yap KP, Ang P, Lim IK, Ho G, Lee AG. Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing. Clin Genet 2006: 70: 80-82.
27. Swensen J, Hoffman M, Skolnick MH, Neuhausen SL. Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum Mol Genet 1997: 6: 1513-1517.
28. Puget N, Gad S, Perrin-Vidoz L et al. Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. Am J Hum Genet 2002: 70: 858-865.
29. Brown MA, Lo LJ, Catteau A et al. Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1: Psi BRCA1 recombination. Hum Mutat 2002: 19: 435-442.
30. Preisler-Adams S, Schonbuchner I, Fiebig B, Welling B, Dworniczak B, Weber BH. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer Genet Cytogenet 2006: 168: 44-49.
31. Agata S, Viel A, Puppa LD et al. Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA 2 point mutations. Genes Chromosomes Cancer 2006: 45: 791-797.
32. Hartmann C, John AL, Klaes R et al. Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 2004: 24: 534.
33. Puget N, Stoppa-Lyonnet D, Sinilnikova OM et al. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 1999: 59: 455-461.
34. Bunyan DJ, Eccles DM, Sillibourne J et al. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 2004: 91: 1155-1159.
35. Gad S, Bieche I, Barrois M et al. Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast-ovarian cancer family. Hum Mutat 2003: 21: 654.
36. de la Hoya M, Gutierrez-Enriquez S, Velasco E et al. Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ ovarian cancer. Clin Chem 2006: 52: 1480-1485.
37. Woodward AM, Davis TA, Silva AG, Kirk JA, Leary JA. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet 2005: 42: E31.
38. Payne SR, Newman B, King MC. Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer. Genes Chromosomes Cancer 2000: 29: 58-62.
39. Ellis D, Patel Y, Yau SC, Hodgson SV, Abbs SJ. Low prevalence of BRCA1 exon rearrangements in familial and young sporadic breast cancer patients. Fam Cancer 2006: 5: 323-326.
40. Gad S, Caux-Moncoutier V, Pages-Berhouet S et al. Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 2002: 21: 6841-6847.
41. Thomassen M, Gerdes AM, Cruger D, Jensen PK, Kruse TA. Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark. Cancer Genet Cytogenet 2006: 168: 168-171.
42. Rohlfs EM, Puget N, Graham ML et al. An Alu -mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer 2000: 28: 300-307.
43. Peixoto A, Salgueiro N, Santos C et al. BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families. Fam Cancer 2006: 5: 379-387.
44. Puget N, Sinilnikova OM, Stoppa-Lyonnet D et al. An Alu -mediated 6-kb duplication in the BRCA1 gene: A new founder mutation? Am J Hum Genet 1999: 64: 300-302.
45. Robinson MD, Chu CE, Turner G, Bishop DT, Taylor GR. Exon deletions and duplications in BRCA1 detected by semiquantitative PCR. Genet Test 2000: 4: 49-54.
46. Iau PT, Marafie M, Ali A et al. Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer. Breast Cancer Res Treat 2004: 85: 81-88.
47. Hofmann W, Wappenschmidt B, Berhane S, Schmutzler R, Scherneck S. Detection of large rearrangements of exons 13 and 22 in the BRCA1 gene in German families. J Med Genet 2002: 39: E36.
48. Hofmann W, Gorgens H, John A et al. Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method. Hum Mutat 2003: 22: 103-104.
49. Kremeyer B, Soller M, Lagerstedt K et al. The BRCA1 exon 13 duplication in the Swedish population. Fam Cancer 2005: 4: 191-194.
50. Petrij-Bosch A, Peelen T, van Vliet M et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997: 17: 341-345.
51. Gad S, Scheuner MT, Pages-Berhouet S et al. Identification of a large rearrangement of the BRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing. J Med Genet 2001: 38: 388-392.
52. Tancredi M, Sensi E, Cipollini G et al. Haplotype analysis of BRCA1 gene reveals a new gene rearrangement: Characterization of a 19.9 KBP deletion. Eur J Hum Genet 2004: 12: 775-777.
53. Ward BD, Hendrickson BC, Judkins T et al. A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotype pair analysis and gene amplification with widely dispersed primer sets. J Mol Diagn 2005: 7: 139-142.
54. Montagna M, Santacatterina M, Torri A et al. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene 1999: 18: 4160-4165.
55. Frolov A, Prowse AH, Vanderveer L, Bove B, Wu H, Godwin AK. DNA array-based method for detection of large rearrangements in the BRCA1 gene. Genes Chromosomes Cancer 2002: 35: 232-241.
56. Rohlfs EM, Chung CH, Yang Q et al. In-frame deletions of BRCA1 may define critical functional domains. Hum Genet 2000: 107: 385-390.
57. van der Looij M, Cleton-Jansen AM, van Eijk R et al. A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1. Genes Chromosomes Cancer 2000: 27: 295-302.
58. Hardouin A, Baumann J, Roussel G, Quillien V, Dugast C, Berthet P. A new mutation in the BRCA1 gene (g.5196-5201del6, 5195-5202ins12), a 6 bp deletion replaced by the duplication of a 12 bp adjacent upstream intronic sequence. Hum Mutat 2001: 17: 154.
59. Carson N, Gilpin C, Hunter A, Allanson J, Aubry H. An in frame deletion of BRCA1 exon 20 in a family with early onset breast and ovarian cancer. Am J Hum Genet 1999: 65: A1610.
60. Belogianni I, Apessos A, Mihalatos M et al. Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer. BMC Cancer 2004: 4: 61.
61. Tournier I, Paillerets BB, Sobol H et al. Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 2004: 64: 8143-8147.
62. Agata S, Dalla Palma M, Callegaro M et al. Large genomic deletions inactivate the BRCA2 gene in breast cancer families. J Med Genet 2005: 42: E64.
63. Wang T, Lerer I, Gueta Z et al. A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: A possible role of the Alu -polyA tail in the evolution of the deletion. Genes Chromosomes Cancer 2001: 31: 91-95.